D.E. Shaw & Co’s Zomedica Corp. ZOM Stock Holding History

D.E. Shaw & Co’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,829	Closed	-$6K	–	5940
2021 Q3	$6K	Buy	+10,829	New	+$6.39K	﹤0.01%	4923

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

D.E. Shaw & Co's ZOM Position: Q4 2021 in Review

D.E. Shaw & Co sold out of Zomedica Corp. (ZOM) in Q4 2021, closing a stake of 10,829 shares — an estimated $6K sold.

D.E. Shaw & Co first reported a position in ZOM in Q3 2021 and held it in 1 quarter. The position peaked at $6K in Q3 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q4 2021.

D.E. Shaw & Co reported no remaining Zomedica Corp. position as of Q4 2021 after selling out during the quarter.
D.E. Shaw & Co sold 10,829 Zomedica Corp. shares in Q4 2021, an estimated $6K.
D.E. Shaw & Co first reported a position in Zomedica Corp. in Q3 2021 and held it in 1 quarter.
D.E. Shaw & Co's Zomedica Corp. position peaked at $6K in Q3 2021.
107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2021.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.